Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
584.05
-0.98 (-0.17%)
May 24, 2024, 4:00 PM EDT - Market closed

Thermo Fisher Revenue

Thermo Fisher had revenue of $42.49B in the twelve months ending March 30, 2024, down -3.00% year-over-year. Revenue in the quarter ending March 30, 2024 was $10.35B, a -3.41% decrease year-over-year. In the year 2023, Thermo Fisher had annual revenue of $42.86B, a decrease of -4.58%.

Revenue (ttm)
$42.49B
Revenue Growth
-3.00%
P/S Ratio
5.25
Revenue / Employee
$348,295
Employees
122,000
Market Cap
222.94B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202342.86B-2.06B-4.58%
Dec 31, 202244.92B5.70B14.55%
Dec 31, 202139.21B6.99B21.71%
Dec 31, 202032.22B6.68B26.14%
Dec 31, 201925.54B1.18B4.86%
Dec 31, 201824.36B3.44B16.45%
Dec 31, 201720.92B2.64B14.47%
Dec 31, 201618.27B1.31B7.72%
Dec 31, 201516.97B75.40M0.45%
Dec 31, 201416.89B3.80B29.02%
Dec 31, 201313.09B580.40M4.64%
Dec 31, 201212.51B951.10M8.23%
Dec 31, 201111.56B1.17B11.22%
Dec 31, 201010.39B481.50M4.86%
Dec 31, 20099.91B-586.40M-5.59%
Dec 31, 200810.50B751.60M7.71%
Dec 31, 20079.75B5.95B157.05%
Dec 31, 20063.79B1.16B44.00%
Dec 31, 20052.63B427.01M19.36%
Dec 31, 20042.21B306.62M16.14%
Dec 31, 20031.90B50.02M2.70%
Dec 28, 20021.85B-338.85M-15.49%
Dec 29, 20012.19B-92.31M-4.05%
Dec 30, 20002.28B-14.10M-0.61%
Jan 1, 20002.29B413.71M22.00%
Jan 2, 19991.88B-98.70M-4.99%
Jan 3, 19981.98B-952.96M-32.50%
Dec 28, 19962.93B662.27M29.17%
Dec 28, 19952.27B541.10M31.29%
Dec 28, 19941.73B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
Pfizer 55.09B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Abbott Laboratories 40.33B
Revenue Rankings